Short communication: UGT1A1*28 variant allele is a predictor of severe hyperbilirubinemia in HIV-infected patients on HAART in Southern Brazil

AIDS Research and Human Retroviruses

Volumn 28, Issue 9, 2012, Pages 815-818

  Turatti, Lisiane ^a   Sprinz, Eduardo ^b   Lazzaretti, Rosmeri K ^b   Kuhmmer, Regina ^b   Agnes, Grasiela ^a   Silveira, Jussara M ^c   Basso, Rossana P ^c   Pinheiro, Cezar A T ^a   Silveira, Mariĝngela F ^a   De Almeida, Silvana ^a   Ribeiro, Jorge P ^b   Mattevi, Vanessa S ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; GLUCURONOSYLTRANSFERASE 1A1; INDINAVIR;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; BRAZIL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; EUROPEAN AMERICAN; FEMALE; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

EID: 84865450619     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0261     Document Type: Article

References (17)

1. Tozzi V: Pharmacogenetics of antiretrovirals. Antiviral Res 2010;85:190-200.
2. Hawkins T: Understanding and managing the adverse effects of antiretroviral therapy. Antiviral Res 2010;85:201-209.
3. Burchell B and Hume R: Molecular genetic basis of Gilbert's syndrome. J Gastroenterol Hepatol 1999;14:960-966. (Pubitemid 29487290)
4. Lankisch TO, Moebius U, Wehmeier M, et al.: Gilbert's disease and atazanavir: From phenotype to UDPglucuronosyltransferase haplotype. Hepatology 2006;44: 1324-1332. (Pubitemid 44748383)
5. Rotger M, Taffé P, Bleiber G, et al.: Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. J Infect Dis 2005;192:1381-1386. (Pubitemid 41401151)
6. Rodriguez-Novoa S, Martín-Carbonero L, Barreiro P, et al.: Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia. AIDS 2007; 21:41-46. (Pubitemid 44912535)
7. Baudhuin LM, Highsmith EW, Skierka J, Holtegaard L, Moore BE, and O'Kane DJ: Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. Clin Biochem 2007;40:710-717. (Pubitemid 46829076)
8. Fellay J, Boubaker K, Ledergerber B, et al.: Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001;358:1322-1327. (Pubitemid 33016496)
9. Smiderle L, Galvaõ ACS, Fontana C, et al.: Evaluation of UGT1A1 and SULT1A1 polymorphisms with lipid levels in women with different hormonal status. Gynecol Endocrinol 2011;27:20-26.
10. Roff DA and Bentzen P: The statistical analysis of mitochondrial DNA polymorphisms: v2 and the problem of small samples. Mol Biol Evol 1989;6:539-545. (Pubitemid 19210236)
11. Zembrzuski VM, Callegari-Jacques SM, and Hutz MH: Application of an African Ancestry Index as a genomic control approach in a Brazilian population. Ann Hum Genet 2006;70:822-828. (Pubitemid 44530646)
12. Azevedo LA, Santin AP, Wagner SC, Zaleski CF, Bock H, Saraiva-Pereira ML, and Castro SM: Prevalence of UGT1A1 gene polymorphism in patients with hemolytic anemia in southern Brazil. Genet Test Mol Biomarkers 2011;15:107-110.
13. Rodriguez-Novoa S, Barreiro P, Jimenez-Nacher I, and Soriano V: Overview of the pharmacogenetics of HIV therapy. Pharmacogenom J 2006;6:234-245. (Pubitemid 44137950)
14. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, and Pena SDJ: Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003;100:177-182. (Pubitemid 36078048)
15. Anderson PL, Lamba J, Aquilante CL, Schuetz E, and Fletcher CV: Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study. J Acquir Immune Defic Syndr 2006;42:441-449. (Pubitemid 44050891)
16. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. Boletim Epidemiológico 2010. Available at http://www.aids.gov.br/publicacao/boletim-epidemiologico- 2010. Accessed 06/30/2011.
17. Pharmacogenomics Knowledge Base (PharmGKB). Available at http://www.pharmgkb.org/images/header/title.png. Accessed 10/07/2011.